[
  {
    "ts": null,
    "headline": "Prime Medicine stock soars amid gene editing sector momentum",
    "summary": "Investing.com -- Prime Medicine (NASDAQ:PRME) stock rose 32%, extending recent gains following Eli Lilly’s (NYSE:LLY) acquisition deal for Verve Therapeutics (NASDAQ:VERV) last month.",
    "url": "https://finnhub.io/api/news?id=cfc2bb0e477033a0add30efaeaffde8623f120a8eab3ddafbd304f87a6c0feb4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751906915,
      "headline": "Prime Medicine stock soars amid gene editing sector momentum",
      "id": 135791618,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investing.com -- Prime Medicine (NASDAQ:PRME) stock rose 32%, extending recent gains following Eli Lilly’s (NYSE:LLY) acquisition deal for Verve Therapeutics (NASDAQ:VERV) last month.",
      "url": "https://finnhub.io/api/news?id=cfc2bb0e477033a0add30efaeaffde8623f120a8eab3ddafbd304f87a6c0feb4"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=44f88a4b4c072ee7f7aabeaa0fe9a44b4bdf78e2c80cf4f4a4392336f37e0a46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751893204,
      "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 135790413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=44f88a4b4c072ee7f7aabeaa0fe9a44b4bdf78e2c80cf4f4a4392336f37e0a46"
    }
  },
  {
    "ts": null,
    "headline": "Here's What to Expect From AbbVie's Next Earnings Report",
    "summary": "AbbVie will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.",
    "url": "https://finnhub.io/api/news?id=933617145a3284bece6fcaa3b9d2e22322ce602690243310e97138116b049fb7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751888119,
      "headline": "Here's What to Expect From AbbVie's Next Earnings Report",
      "id": 135790414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.",
      "url": "https://finnhub.io/api/news?id=933617145a3284bece6fcaa3b9d2e22322ce602690243310e97138116b049fb7"
    }
  },
  {
    "ts": null,
    "headline": "2 ETFs To Prepare You For A Potential Recession",
    "summary": "I see a 50-60% chance of a recession in the next 12â24 months, so portfolio preparation is essential. Read why I recommend IAUM and DGRO ETFs.",
    "url": "https://finnhub.io/api/news?id=cc505f6b616720afc1986328e03a7a18125918d9f3f4d05d0a80fbb4227712c0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751871000,
      "headline": "2 ETFs To Prepare You For A Potential Recession",
      "id": 135784553,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1129173988/image_1129173988.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "I see a 50-60% chance of a recession in the next 12â24 months, so portfolio preparation is essential. Read why I recommend IAUM and DGRO ETFs.",
      "url": "https://finnhub.io/api/news?id=cc505f6b616720afc1986328e03a7a18125918d9f3f4d05d0a80fbb4227712c0"
    }
  }
]